Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Leukemia, Myeloid × Sensitivity and Specificity × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Follicular 3 Leukemia, Prolymphocytic, B-Cell 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Leukemia, Myeloid, Acute 2 Stomach Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Multiple Myeloma 1 Lymphoma, T-Cell 1 Lymphoma, Extranodal NK-T-Cell 1 Leukemia, Prolymphocytic, T-Cell 1 Leukemia, Myeloid 1 Leukemia, Large Granular Lymphocytic 1 Immunoblastic Lymphadenopathy 1 Enteropathy-Associated T-Cell Lymphoma 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1

Interventions

zosuquidar trihydrochloride 2 venetoclax 2 Immunotherapy, Adoptive 2 Cytarabine 2 ponatinib 1 gilteritinib 1 enasidenib 1 Sensitivity and Specificity 1 N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide 1 Gemtuzumab 1 Daunorubicin 1 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-trifluoromethylphenyl)-3-(4-pyrazin-2-ylpyrimidin-2-ylamino)benzamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01864902 2016-01-28

CART33

Chinese PLA General Hospital

Phase 1/2 Unknown

Other hematologic neoplasm

Leukemia, Myeloid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡